Status:
COMPLETED
Negative Pressure Therapy, Minimally Invasive and Accessible Technique in the Treatment of Massive Subcutaneous Emphysema in COVID-19 or Non Infected Critical Patients
Lead Sponsor:
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Conditions:
Subcutaneous Emphysema
Covid19
Eligibility:
All Genders
Brief Summary
Background Numerous surgicals treatments have been described for the massive subcutaneous emphysema; however, some of these techniques cannot be carried out in a critical care unit and they are relate...
Eligibility Criteria
Inclusion
- Subcutaneous emphysema that compromises ventilation
Exclusion
- Declined Therapy
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT04840953
Start Date
December 1 2020
End Date
February 1 2021
Last Update
April 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General Universitario de Elche
Elche, Alicante, Spain, 03203